English
French
Sweet taste receptor inhibitors: Potential treatment for equine insulin dysregulation.
Abstract: Hyperinsulinemia is a major risk factor for equine laminitis, a debilitating and painful foot condition. Sweet taste receptor (T1R2/3) inhibitors have been used to reduce the insulin and glucose responses to oral carbohydrates in other species. However, their effect in horses has not been investigated. It would be useful to be able to attenuate the large post-prandial insulin response that typically occurs when a carbohydrate-rich meal is fed to insulin-dysregulated horses. Here we have determined the efficacy of two T1R2/3 inhibitors, lactisole and Gymnema sylvestre, for reducing glucose uptake by the equine small intestine in vitro; and post-prandial insulin secretion in ponies in vivo, following a carbohydrate-based meal. We used gas chromatography-mass spectrometry to measure 2-deoxyglucose uptake by explants of small intestine, in the presence and absence of the T1R2/3 inhibitors. Lactisole and G sylvestre reduced 2-deoxyglucose uptake by the intestinal explants by 63% (P = 0.032) and 73% (P = 0.047), respectively, compared to control samples. The study in vivo investigated the effect of the inhibitors on the blood glucose and serum insulin responses to a meal containing D-glucose. Three doses of each inhibitor were tested using a Latin square design, and each dose was compared to a meal with no inhibitor added. Lactisole had no effect on glucose and insulin concentrations, whereas G sylvestre was partially effective at reducing post-prandial blood glucose (by ~10%) and serum insulin concentrations (~25%) in seven ponies, with a most effective dose of 10 mg/kg bodyweight. These data provide preliminary support that T1R2/3 inhibitors may be a useful therapeutic strategy for the management of equine insulin dysregulation and the prevention of laminitis. However, further optimisation of the dose and delivery method for these compounds is required, as well as a direct investigation of their activity on the equine sweet taste receptor.
Publication Date: 2018-06-29 PubMed ID: 29958298PubMed Central: PMC6025858DOI: 10.1371/journal.pone.0200070Google Scholar: Lookup The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
- Research Support
- Non-U.S. Gov't
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The researchers studied the effects of sweet taste receptor inhibitors in horses to combat insulin imbalance associated with high-carb meals, a key risk factor for equine laminitis. The two inhibitors in focus were lactisole and Gymnema sylvestre, known to reduce insulin and glucose responses. Results demonstrated the partial effectiveness of G. sylvestre in lowering post-meal blood glucose and insulin levels, while lactisole had no significant effect.
Research Methodology
- The efficacy of the sweet taste receptor inhibitors lactisole and Gymnema sylvestre in cutting glucose absorption by the equine small intestine was investigated through in vitro analysis.
- Post-meal insulin secretion was also examined following a carbohydrate-based diet in vivo in ponies.
- Gas chromatography-mass spectrometry was used to measure 2-deoxyglucose intake by small intestine samples, both with and without the addition of the inhibitors.
- In the in vivo study, the blood glucose and serum insulin responses to a meal containing D-glucose were measured. Three dose levels of each inhibitor were trialled using a Latin square design, with each dose compared against a meal with no inhibitor.
Key Findings
- Both lactisole and Gymnema sylvestre have been shown to reduce 2-deoxyglucose uptake by the intestinal samples by 63% and 73% respectively.
- In the in vivo study, G. sylvestre worked to lower post-meal blood glucose levels by around 10% and serum insulin levels by 25% in the tested ponies. The optimum dosage of G. sylvestre proposed by the study was 10 mg/kg body weight.
- Lactisole, on the other hand, showed no significant impact on glucose and insulin levels in the ponies.
Conclusions and Suggestions for Further Research
- The research has marked potential for using T1R2/3 inhibitors to manage equine insulin dysregulation and prevent laminitis, with preliminary support for G. sylvestre specifically.
- However, further fine-tuning of the dosage and administering method for the respective compounds is required for stretchier effectiveness.
- Moreover, direct research investigating the inhibitors’ activity on the equine sweet taste receptor is also recommended to further understand and optimize their potential benefits.
Cite This Article
APA
de Laat MA, Kheder MH, Pollitt CC, Sillence MN.
(2018).
Sweet taste receptor inhibitors: Potential treatment for equine insulin dysregulation.
PLoS One, 13(6), e0200070.
https://doi.org/10.1371/journal.pone.0200070 Publication
Researcher Affiliations
- School of Earth, Environmental and Biological Sciences, Queensland University of Technology, Brisbane, Queensland, Australia.
- School of Earth, Environmental and Biological Sciences, Queensland University of Technology, Brisbane, Queensland, Australia.
- School of Veterinary Science, The University of Queensland, Gatton, Queensland, Australia.
- School of Earth, Environmental and Biological Sciences, Queensland University of Technology, Brisbane, Queensland, Australia.
MeSH Terms
- Animals
- Benzene Derivatives / pharmacology
- Gymnema sylvestre
- Horse Diseases / blood
- Horse Diseases / drug therapy
- Horses
- Hyperinsulinism / blood
- Hyperinsulinism / drug therapy
- Hyperinsulinism / veterinary
- Insulin / blood
- Intestinal Absorption / drug effects
- Intestine, Small / metabolism
- Receptors, G-Protein-Coupled / antagonists & inhibitors
- Receptors, G-Protein-Coupled / metabolism
Conflict of Interest Statement
The authors have declared that no competing interests exist.
References
This article includes 49 references
- Pollitt CC. Equine laminitis. Clinical Techniques in Equine Practice. 2004;3(1):34u201344. PubMed PMID: CABI:20053021958.
- de Laat MA, McGowan CM, Sillence MN, Pollitt CC. Equine laminitis: induced by 48 h hyperinsulinaemia in Standardbred horses.. Equine Vet J 2010 Mar;42(2):129-35.
- Johnson PJ, Messer NT, Slight SH, Wiedmeyer C, Buff P, Ganjam VK. Endocrinopathic laminitis in the horse. Clinical Techniques in Equine Practice. 2004;3(1):45u201356. PubMed PMID: CABI:20053021959.
- de Laat MA, McGree JM, Sillence MN. Equine hyperinsulinemia: investigation of the enteroinsular axis during insulin dysregulation.. Am J Physiol Endocrinol Metab 2016 Jan 1;310(1):E61-72.
- Geor RJ, Harris P. Dietary management of obesity and insulin resistance: countering risk for laminitis.. Vet Clin North Am Equine Pract 2009 Apr;25(1):51-65, vi.
- Maillet EL. [Modulation of T1R chemosensory receptors for sweet nutrients - new paradigms in metabolic regulation].. Med Sci (Paris) 2011 Feb;27(2):177-82.
- Nguyen CA, Akiba Y, Kaunitz JD. Recent advances in gut nutrient chemosensing.. Curr Med Chem 2012;19(1):28-34.
- Dyer J, Salmon KS, Zibrik L, Shirazi-Beechey SP. Expression of sweet taste receptors of the T1R family in the intestinal tract and enteroendocrine cells.. Biochem Soc Trans 2005 Feb;33(Pt 1):302-5.
- Daly K, Al-Rammahi M, Arora DK, Moran AW, Proudman CJ, Ninomiya Y, Shirazi-Beechey SP. Expression of sweet receptor components in equine small intestine: relevance to intestinal glucose transport.. Am J Physiol Regul Integr Comp Physiol 2012 Jul 15;303(2):R199-208.
- Young RL. Sensing via intestinal sweet taste pathways.. Front Neurosci 2011;5:23.
- Steinert RE, Gerspach AC, Gutmann H, Asarian L, Drewe J, Beglinger C. The functional involvement of gut-expressed sweet taste receptors in glucose-stimulated secretion of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY).. Clin Nutr 2011 Aug;30(4):524-32.
- Shirazi-Beechey SP, Daly K, Al-Rammahi M, Moran AW, Bravo D. Role of nutrient-sensing taste 1 receptor (T1R) family members in gastrointestinal chemosensing.. Br J Nutr 2014 Jun;111 Suppl 1:S8-15.
- Jang HJ, Kokrashvili Z, Theodorakis MJ, Carlson OD, Kim BJ, Zhou J, Kim HH, Xu X, Chan SL, Juhaszova M, Bernier M, Mosinger B, Margolskee RF, Egan JM. Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1.. Proc Natl Acad Sci U S A 2007 Sep 18;104(38):15069-74.
- Drucker DJ. Incretin action in the pancreas: potential promise, possible perils, and pathological pitfalls.. Diabetes 2013 Oct;62(10):3316-23.
- Gilor C, Graves TK, Gilor S, Ridge TK, Weng HY, Dossin O. The incretin effect in cats: comparison between oral glucose, lipids, and amino acids.. Domest Anim Endocrinol 2011 May;40(4):205-12.
- Kyriazis GA, Smith KR, Tyrberg B, Hussain T, Pratley RE. Sweet taste receptors regulate basal insulin secretion and contribute to compensatory insulin hypersecretion during the development of diabetes in male mice.. Endocrinology 2014 Jun;155(6):2112-21.
- Harada S, Kasahara Y. Inhibitory effect of gurmarin on palatal taste responses to amino acids in the rat.. Am J Physiol Regul Integr Comp Physiol 2000 Jun;278(6):R1513-7.
- Sigoillot M, Brockhoff A, Meyerhof W, Briand L. Sweet-taste-suppressing compounds: current knowledge and perspectives of application.. Appl Microbiol Biotechnol 2012 Nov;96(3):619-30.
- Jiang P, Cui M, Zhao B, Liu Z, Snyder LA, Benard LM, Osman R, Margolskee RF, Max M. Lactisole interacts with the transmembrane domains of human T1R3 to inhibit sweet taste.. J Biol Chem 2005 Apr 15;280(15):15238-46.
- Hamano K, Nakagawa Y, Ohtsu Y, Li L, Medina J, Tanaka Y, Masuda K, Komatsu M, Kojima I. Lactisole inhibits the glucose-sensing receptor T1R3 expressed in mouse pancreatic u03b2-cells.. J Endocrinol 2015 Jul;226(1):57-66.
- Winnig M, Bufe B, Meyerhof W. Valine 738 and lysine 735 in the fifth transmembrane domain of rTas1r3 mediate insensitivity towards lactisole of the rat sweet taste receptor.. BMC Neurosci 2005 Apr 7;6:22.
- Fushiki T, Kojima A, Imoto T, Inoue K, Sugimoto E. An extract of Gymnema sylvestre leaves and purified gymnemic acid inhibits glucose-stimulated gastric inhibitory peptide secretion in rats.. J Nutr 1992 Dec;122(12):2367-73.
- Shimizu K, Iino A, Nakajima J, Tanaka K, Nakajyo S, Urakawa N, Atsuchi M, Wada T, Yamashita C. Suppression of glucose absorption by some fractions extracted from Gymnema sylvestre leaves.. J Vet Med Sci 1997 Apr;59(4):245-51.
- Khan V, Najmi AK, Akhtar M, Aqil M, Mujeeb M, Pillai KK. A pharmacological appraisal of medicinal plants with antidiabetic potential.. J Pharm Bioallied Sci 2012 Jan;4(1):27-42.
- Sanematsu K, Kusakabe Y, Shigemura N, Hirokawa T, Nakamura S, Imoto T, Ninomiya Y. Molecular mechanisms for sweet-suppressing effect of gymnemic acids.. J Biol Chem 2014 Sep 12;289(37):25711-20.
- Hellekant G, Gopal V. On the effects of gymnemic acid in the hamster and rat.. Acta Physiol Scand 1976 Oct;98(2):136-42.
- Hellekant G, Ninomiya Y, DuBois GE, Danilova V, Roberts TW. Taste in chimpanzee: I. The summated response to sweeteners and the effect of gymnemic acid.. Physiol Behav 1996 Aug;60(2):469-79.
- Ninomiya Y, Imoto T. Gurmarin inhibition of sweet taste responses in mice.. Am J Physiol 1995 Apr;268(4 Pt 2):R1019-25.
- Uchida Y, Sato T. Changes in outward K+ currents in response to two types of sweeteners in sweet taste transduction of gerbil taste cells.. Chem Senses 1997 Apr;22(2):163-9.
- Kheder MH, Bailey SR, Dudley KJ, Sillence MN, de Laat MA. Equine glucagon-like peptide-1 receptor physiology.. PeerJ 2018;6:e4316.
- Al-Romaiyan A, King AJ, Persaud SJ, Jones PM. A novel extract of Gymnema sylvestre improves glucose tolerance in vivo and stimulates insulin secretion and synthesis in vitro.. Phytother Res 2013 Jul;27(7):1006-11.
- Henneke DR, Potter GD, Kreider JL, Yeates BF. Relationship between condition score, physical measurements and body fat percentage in mares.. Equine Vet J 1983 Oct;15(4):371-2.
- Carter RA, Geor RJ, Burton Staniar W, Cubitt TA, Harris PA. Apparent adiposity assessed by standardised scoring systems and morphometric measurements in horses and ponies.. Vet J 2009 Feb;179(2):204-10.
- Bera R, Kundu A, Sen T, Adhikari D, Karmakar S. In Vitro Metabolic Stability and Permeability of Gymnemagenin and Its In Vivo Pharmacokinetic Correlation in Rats - A Pilot Study.. Planta Med 2016 Apr;82(6):544-50.
- Schiffman SS, Booth BJ, Sattely-Miller EA, Graham BG, Gibes KM. Selective inhibition of sweetness by the sodium salt of +/-2-(4-methoxyphenoxy)propanoic acid.. Chem Senses 1999 Aug;24(4):439-47.
- Leach MJ. Gymnema sylvestre for diabetes mellitus: a systematic review.. J Altern Complement Med 2007 Nov;13(9):977-83.
- de Laat MA, Sillence MN. The repeatability of an oral glucose test in ponies.. Equine Vet J 2017 Mar;49(2):238-243.
- Tinworth KD, Wynn PC, Boston RC, Harris PA, Sillence MN, Thevis M, Thomas A, Noble GK. Evaluation of commercially available assays for the measurement of equine insulin.. Domest Anim Endocrinol 2011 Aug;41(2):81-90.
- Frank N, Tadros EM. Insulin dysregulation.. Equine Vet J 2014 Jan;46(1):103-12.
- Mace OJ, Affleck J, Patel N, Kellett GL. Sweet taste receptors in rat small intestine stimulate glucose absorption through apical GLUT2.. J Physiol 2007 Jul 1;582(Pt 1):379-92.
- Young RL, Sutherland K, Pezos N, Brierley SM, Horowitz M, Rayner CK, Blackshaw LA. Expression of taste molecules in the upper gastrointestinal tract in humans with and without type 2 diabetes.. Gut 2009 Mar;58(3):337-46.
- Gorboulev V, Schu00fcrmann A, Vallon V, Kipp H, Jaschke A, Klessen D, Friedrich A, Scherneck S, Rieg T, Cunard R, Veyhl-Wichmann M, Srinivasan A, Balen D, Breljak D, Rexhepaj R, Parker HE, Gribble FM, Reimann F, Lang F, Wiese S, Sabolic I, Sendtner M, Koepsell H. Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion.. Diabetes 2012 Jan;61(1):187-96.
- Nguyen NQ, Debreceni TL, Bambrick JE, Chia B, Wishart J, Deane AM, Rayner CK, Horowitz M, Young RL. Accelerated intestinal glucose absorption in morbidly obese humans: relationship to glucose transporters, incretin hormones, and glycemia.. J Clin Endocrinol Metab 2015 Mar;100(3):968-76.
- Merritt AM. Normal equine gastroduodenal secretion and motility.. Equine Vet J Suppl 1999 Apr;(29):7-13.
- Linardi RL, Stokes AM, Keowen ML, Barker SA, Hosgood GL, Short CR. Bioavailability and pharmacokinetics of oral and injectable formulations of methadone after intravenous, oral, and intragastric administration in horses.. Am J Vet Res 2012 Feb;73(2):290-5.
- Serrano-Rodru00edguez JM, Gu00f3mez-Du00edez M, Esgueva M, Casteju00f3n-Riber C, Mena-Bravo A, Priego-Capote F, Ayala N, Caballero JMS, Muu00f1oz A. Pharmacokinetic/pharmacodynamic modeling of benazepril and benazeprilat after administration of intravenous and oral doses of benazepril in healthy horses.. Res Vet Sci 2017 Oct;114:117-122.
- Hustace JL, Firshman AM, Mata JE. Pharmacokinetics and bioavailability of metformin in horses.. Am J Vet Res 2009 May;70(5):665-8.
- Bamford NJ, Baskerville CL, Harris PA, Bailey SR. Postprandial glucose, insulin, and glucagon-like peptide-1 responses of different equine breeds adapted to meals containing micronized maize.. J Anim Sci 2015 Jul;93(7):3377-83.
- Kumar V, Bhandari U, Tripathi CD, Khanna G. Anti-obesity effect of Gymnema sylvestre extract on high fat diet-induced obesity in Wistar rats.. Drug Res (Stuttg) 2013 Dec;63(12):625-32.
Citations
This article has been cited 1 times.- Durham AE, Frank N, McGowan CM, Menzies-Gow NJ, Roelfsema E, Vervuert I, Feige K, Fey K. ECEIM consensus statement on equine metabolic syndrome.. J Vet Intern Med 2019 Mar;33(2):335-349.
Secure Payments
Satisfaction Guarantee
We offer a 60-day guarantee to ensure you are completely satisfied.
Fast & Free Shipping
We provide fast and free shipping on all orders over $40.